The Curing Company is proposing a new business model to address the challenges faced by the healthcare industry. The traditional approach of developing treatments for common diseases has resulted in a focus on "one size fits all" models, which ignore individual patient specificities and disease diversity. This has led to a limited reactive operating mode, where patients are only treated after they become sick. The new model aims to use available technologies to achieve the necessary transformation and address the needs of patients with rarer diseases. The article suggests that prevention is better than cure and highlights the importance of addressing the needs of patients with rarer diseases.
